Last reviewed · How we verify
Aspirin interruption
At a glance
| Generic name | Aspirin interruption |
|---|---|
| Also known as | Aspirin interruption (drug) |
| Sponsor | Kyoto University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding
- Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy (PHASE3)
- Pomalidomide as an Immune-enhancing Agent for the Control of HIV (PHASE1, PHASE2)
- Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation (PHASE4)
- Chronic Subdural Hematoma and Aspirin (NA)
- Safety of Cold Snare Polypectomy in Patients With Uninterrupted Antiplatelet Agent
- XIENCE 28 USA Study (NA)
- XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |